March 23, 2022 -- Calyx has been designated as a partner of the clinical research organization ProTrials Research to strengthen its capabilities for production of strong and well-managed clinical trial outcomes data using Calyx's eClinical solutions.
Through this partnership, ProTrials will be able to better assist its customers in meeting their clinical development objectives throughout the drug development process, the companies said.
Calyx will specifically offer its services in medical imaging, interactive response technology, and electronic data capture solutions to promote the output of reliable and comprehensive clinical trial outcomes data.
Furthermore, the collaboration will provide ProTrials' customers with the organization and analysis needed to develop safe and effective medications from the clinical trial process, the companies said.
Copyright © 2022 scienceboard.net